Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert E Kalb

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Dermatology Online Journal|September 30, 2010
Nodular lymphangitis: Report of a case with presentation of a diagnostic paradigmCerrene Nicole Giordano, Robert E Kalb, Corstiaan Brass, et al.
North American Journal of Medical Sciences|November 20, 2013
The presentation, pathology, and current management strategies of cutaneous metastasisChristina Yin Bin Wong, Meghan A Helm, Robert E Kalb, et al.
European Journal of Dermatology : EJD|June 29, 2018
Greater improvement in quality of life outcomes in patients using fixed-combination calcipotriol plus betamethasone dipropionate aerosol foam versus gel: results from the PSO-ABLE studyChristopher Em Griffiths, Linda Stein Gold, Frédéric Cambazard, et al.
Journal of the American Academy of Dermatology|December 24, 2008
Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis FoundationRobert E Kalb, Jerry Bagel, Neil J Korman, et al.
Journal of the American Academy of Dermatology|May 22, 2012
Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis FoundationAmanda Robinson, Abby S Van Voorhees, Sylvia Hsu, et al.
Journal of Drugs in Dermatology : JDD|August 30, 2013
Effect of infliximab on health-related quality of life and disease activity by body region in patients with moderate-to-severe psoriasis and inadequate response to etanercept: results from the PSUNRISE trialRobert E Kalb, Andrew Blauvelt, Howard L Sofen, et al.
JAAD International|August 19, 2021
Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis CouncilArnon D Cohen, Ronald Vender, Luigi Naldi, et al.
Journal of the American Academy of Dermatology|April 21, 2009
Treatment of severe scalp psoriasis: from the Medical Board of the National Psoriasis FoundationC Stanley Chan, Abby S Van Voorhees, Mark G Lebwohl, et al.
Journal of the American Academy of Dermatology|August 4, 2009
Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis FoundationKavita Menon, Abby S Van Voorhees, Bruce F Bebo, et al.
American Journal of Clinical Dermatology|September 30, 2018
Effect of Age of Onset of Psoriasis on Clinical Outcomes with Systemic Treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)Sanminder Singh, Robert E Kalb, Elke M G J de Jong, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Dermatology Online Journal|September 30, 2010
Nodular lymphangitis: Report of a case with presentation of a diagnostic paradigmCerrene Nicole Giordano, Robert E Kalb, Corstiaan Brass, et al.
North American Journal of Medical Sciences|November 20, 2013
The presentation, pathology, and current management strategies of cutaneous metastasisChristina Yin Bin Wong, Meghan A Helm, Robert E Kalb, et al.
European Journal of Dermatology : EJD|June 29, 2018
Greater improvement in quality of life outcomes in patients using fixed-combination calcipotriol plus betamethasone dipropionate aerosol foam versus gel: results from the PSO-ABLE studyChristopher Em Griffiths, Linda Stein Gold, Frédéric Cambazard, et al.
Journal of the American Academy of Dermatology|December 24, 2008
Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis FoundationRobert E Kalb, Jerry Bagel, Neil J Korman, et al.
Journal of the American Academy of Dermatology|May 22, 2012
Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis FoundationAmanda Robinson, Abby S Van Voorhees, Sylvia Hsu, et al.
Journal of Drugs in Dermatology : JDD|August 30, 2013
Effect of infliximab on health-related quality of life and disease activity by body region in patients with moderate-to-severe psoriasis and inadequate response to etanercept: results from the PSUNRISE trialRobert E Kalb, Andrew Blauvelt, Howard L Sofen, et al.
JAAD International|August 19, 2021
Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis CouncilArnon D Cohen, Ronald Vender, Luigi Naldi, et al.
Journal of the American Academy of Dermatology|April 21, 2009
Treatment of severe scalp psoriasis: from the Medical Board of the National Psoriasis FoundationC Stanley Chan, Abby S Van Voorhees, Mark G Lebwohl, et al.
Journal of the American Academy of Dermatology|August 4, 2009
Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis FoundationKavita Menon, Abby S Van Voorhees, Bruce F Bebo, et al.
American Journal of Clinical Dermatology|September 30, 2018
Effect of Age of Onset of Psoriasis on Clinical Outcomes with Systemic Treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)Sanminder Singh, Robert E Kalb, Elke M G J de Jong, et al.
Pageof 5